Liver and pancreatic injury induced by antituberculous therapy.
Markov
M
M
Department of Medicine, Maricopa Medical Center, 2601 East Roosevelt Street, Phoenix, Arizona 85008, USA.
Patel
K
K
Raeesy
A
A
Bant
A
A
Van Thiel
D H
DH
Nadir
A
A
D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D001706:Biopsy; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery; D002760:Cholangiopancreatography, Endoscopic Retrograde / Q000379:methods; D004977:Ethambutol / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis / Q000601:surgery; D011718:Pyrazinamide / Q000009:adverse effects; D012293:Rifampin / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D014376:Tuberculosis / Q000188:drug therapy*
D000995:Antitubercular Agents; D011718:Pyrazinamide; D004977:Ethambutol; D012293:Rifampin